title: Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
authors.forename: S
authors.initials: S
authors.lastname: Taniguchi
authors.forename: K
authors.initials: K
authors.lastname: Yamasaki
authors.forename: T
authors.initials: T
authors.lastname: Shibuya
authors.forename: R
authors.initials: R
authors.lastname: Asayama
authors.forename: M
authors.initials: M
authors.lastname: Harada
authors.forename: Y
authors.initials: Y
authors.lastname: Niho
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000293:Adolescent; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D001787:Blood Group Incompatibility; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000017:ABO Blood-Group System; D007155:Immunologic Factors; D011994:Recombinant Proteins; D004921:Erythropoietin